Monica Diez-Fairen1, Sara Bandres-Ciga2, Gabrielle Houle3, Mike A Nalls4, Simon L Girard5, Patrick A Dion6, Cornelis Blauwendraat7, Andrew B Singleton7, Guy A Rouleau8, Pau Pastor9. 1. Fundació Docència i Recerca Mútua Terrassa, University Hospital Mútua de Terrassa, Terrassa, 08221, Barcelona, Spain; Movement Disorders Unit, Department of Neurology, University Hospital Mútua de Terrassa, Terrassa, 08222, Barcelona, Spain. 2. Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, 20892, MD, USA; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, 18016, Spain. 3. Department of Human Genetics, McGill University, Montréal, H3A 2B4, Quebec, Canada; Montreal Neurological Institute, McGill University, Montréal, H3A 2B4, Quebec, Canada. 4. Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, 20892, MD, USA; Data Tecnica International, Glen Echo, 20892, Bethesda, MD, USA. 5. Centre Intersectoriel en Santé Durable, Université du Québec, Chicoutimi, G7H 2B1, Quebec, Canada. 6. Department of Human Genetics, McGill University, Montréal, H3A 2B4, Quebec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, H3A 2B4, Quebec, Canada. 7. Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, 20892, MD, USA. 8. Montreal Neurological Institute, McGill University, Montréal, H3A 2B4, Quebec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, H3A 2B4, Quebec, Canada. 9. Fundació Docència i Recerca Mútua Terrassa, University Hospital Mútua de Terrassa, Terrassa, 08221, Barcelona, Spain; Movement Disorders Unit, Department of Neurology, University Hospital Mútua de Terrassa, Terrassa, 08222, Barcelona, Spain. Electronic address: pastorpau@gmail.com.
Abstract
INTRODUCTION: Despite considerable efforts to identify disease-causing and risk factors contributing to essential tremor (ET), no comprehensive assessment of heritable risk has been performed to date. METHODS: We use GREML-LDMS to estimate narrow-sense heritability due to additive effects (h2) and GREMLd to calculate non-additive heritability due to dominance variance (δ2) using data from 1,751 ET cases and 5,311 controls. We evaluate heritability per 10 Mb segments across the genome and assess the impact of Parkinson's disease (PD) misdiagnosis on heritability estimates. We apply genetic risk score (GRS) from PD and restless legs syndrome (RLS) to explore its contribution to ET risk and further assess genetic correlations with 832 traits by Linkage disequilibrium score regression. RESULTS: We estimated ET narrow-sense heritability to be h2 = 75.5% (s.e = ±0.075). In contrast, dominance variance showed insignificant effect on the overall estimates. Heritability split by 10 Mb regions revealed increased estimates at chromosomes 6 and 21. The proportion of genetic variance due to PD misdiagnosed cases was estimated to be 5.33%. PD and RLS GRS were not significantly predictive of ET case-control status. CONCLUSIONS: We show for the first time that ET is a highly heritable condition in which additive common variability plays a prominent role. Chromosomes 6 and 21 may contain causative risk variants influencing susceptibility to ET. Despite overlapping symptomatology, ET does not seem to share genetic etiologies with PD or RLS. Our study suggests that most of ET genetic component is yet to be discovered and future GWAS will reveal additional risk factors contributing to ET.
INTRODUCTION: Despite considerable efforts to identify disease-causing and risk factors contributing to essential tremor (ET), no comprehensive assessment of heritable risk has been performed to date. METHODS: We use GREML-LDMS to estimate narrow-sense heritability due to additive effects (h2) and GREMLd to calculate non-additive heritability due to dominance variance (δ2) using data from 1,751 ET cases and 5,311 controls. We evaluate heritability per 10 Mb segments across the genome and assess the impact of Parkinson's disease (PD) misdiagnosis on heritability estimates. We apply genetic risk score (GRS) from PD and restless legs syndrome (RLS) to explore its contribution to ET risk and further assess genetic correlations with 832 traits by Linkage disequilibrium score regression. RESULTS: We estimated ET narrow-sense heritability to be h2 = 75.5% (s.e = ±0.075). In contrast, dominance variance showed insignificant effect on the overall estimates. Heritability split by 10 Mb regions revealed increased estimates at chromosomes 6 and 21. The proportion of genetic variance due to PD misdiagnosed cases was estimated to be 5.33%. PD and RLS GRS were not significantly predictive of ET case-control status. CONCLUSIONS: We show for the first time that ET is a highly heritable condition in which additive common variability plays a prominent role. Chromosomes 6 and 21 may contain causative risk variants influencing susceptibility to ET. Despite overlapping symptomatology, ET does not seem to share genetic etiologies with PD or RLS. Our study suggests that most of ET genetic component is yet to be discovered and future GWAS will reveal additional risk factors contributing to ET.
Authors: Sara Bandrés-Ciga; Timothy Ryan Price; Francisco Javier Barrero; Francisco Escamilla-Sevilla; Javier Pelegrina; Sampath Arepalli; Dena Hernández; Blanca Gutiérrez; Jorge Cervilla; Margarita Rivera; Alberto Rivera; Jing-Hui Ding; Francisco Vives; Michael Nalls; Andrew Singleton; Raquel Durán Journal: Neurobiol Aging Date: 2016-06-11 Impact factor: 4.673
Authors: Hreinn Stefansson; Stacy Steinberg; Hjorvar Petursson; Omar Gustafsson; Iris H Gudjonsdottir; Gudrun A Jonsdottir; Stefan T Palsson; Thorlakur Jonsson; Jona Saemundsdottir; Gyda Bjornsdottir; Yvonne Böttcher; Theodora Thorlacius; Dietrich Haubenberger; Alexander Zimprich; Eduard Auff; Christoph Hotzy; Claudia M Testa; Lisa A Miyatake; Ami R Rosen; Kristleifur Kristleifsson; David Rye; Friedrich Asmus; Ludger Schöls; Martin Dichgans; Finnbogi Jakobsson; John Benedikz; Unnur Thorsteinsdottir; Jeffrey Gulcher; Augustine Kong; Kari Stefansson Journal: Nat Genet Date: 2009-02-01 Impact factor: 38.330
Authors: Stefanie H Müller; Simon L Girard; Franziska Hopfner; Nancy D Merner; Cynthia V Bourassa; Delia Lorenz; Lorraine N Clark; Lukas Tittmann; Alexandra I Soto-Ortolaza; Stephan Klebe; Mark Hallett; Susanne A Schneider; Colin A Hodgkinson; Wolfgang Lieb; Zbigniew K Wszolek; Manuela Pendziwiat; Oswaldo Lorenzo-Betancor; Werner Poewe; Sara Ortega-Cubero; Klaus Seppi; Alex Rajput; Anna Hussl; Ali H Rajput; Daniela Berg; Patrick A Dion; Isabel Wurster; Joshua M Shulman; Karin Srulijes; Dietrich Haubenberger; Pau Pastor; Carles Vilariño-Güell; Ronald B Postuma; Geneviève Bernard; Karl-Heinz Ladwig; Nicolas Dupré; Joseph Jankovic; Konstantin Strauch; Michel Panisset; Juliane Winkelmann; Claudia M Testa; Eva Reischl; Kirsten E Zeuner; Owen A Ross; Thomas Arzberger; Sylvain Chouinard; Günther Deuschl; Elan D Louis; Gregor Kuhlenbäumer; Guy A Rouleau Journal: Brain Date: 2016-10-20 Impact factor: 13.501
Authors: Jian Yang; Andrew Bakshi; Zhihong Zhu; Gibran Hemani; Anna A E Vinkhuyzen; Sang Hong Lee; Matthew R Robinson; John R B Perry; Ilja M Nolte; Jana V van Vliet-Ostaptchouk; Harold Snieder; Tonu Esko; Lili Milani; Reedik Mägi; Andres Metspalu; Anders Hamsten; Patrik K E Magnusson; Nancy L Pedersen; Erik Ingelsson; Nicole Soranzo; Matthew C Keller; Naomi R Wray; Michael E Goddard; Peter M Visscher Journal: Nat Genet Date: 2015-08-31 Impact factor: 38.330
Authors: Jie Zheng; A Mesut Erzurumluoglu; Benjamin L Elsworth; John P Kemp; Laurence Howe; Philip C Haycock; Gibran Hemani; Katherine Tansey; Charles Laurin; Beate St Pourcain; Nicole M Warrington; Hilary K Finucane; Alkes L Price; Brendan K Bulik-Sullivan; Verneri Anttila; Lavinia Paternoster; Tom R Gaunt; David M Evans; Benjamin M Neale Journal: Bioinformatics Date: 2016-09-22 Impact factor: 6.937
Authors: Monica Diez-Fairen; Gabrielle Houle; Sara Ortega-Cubero; Sara Bandres-Ciga; Ignacio Alvarez; Maria Carcel; Laura Ibañez; Maria Victoria Fernandez; John P Budde; Jean-Rémi Trotta; Raúl Tonda; Jessica X Chong; Michael J Bamshad; Deborah A Nickerson; Miquel Aguilar; Juan P Tartari; Alexandre Gironell; Elena García-Martín; Jose Ag Agundez; Hortensia Alonso-Navarro; Felix Javier Jimenez-Jimenez; Manel Fernandez; Francesc Valldeoriola; Maria Jose Marti; Eduard Tolosa; Francisco Coria; Maria A Pastor; Carles Vilariño-Güell; Alex Rajput; Patrick A Dion; Carlos Cruchaga; Guy A Rouleau; Pau Pastor Journal: Parkinsonism Relat Disord Date: 2020-11-24 Impact factor: 4.891
Authors: Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; Ignacio Álvarez; Pau Pastor; José A G Agúndez Journal: Pharmaceuticals (Basel) Date: 2021-05-27